{"nct_id":"NCT07190300","title":"TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)","status":"NOT_YET_RECRUITING","status_verified_date":"2025-09","start_date":"2025-11-03","start_date_type":"ESTIMATED","primary_completion_date":"2032-05-14","primary_completion_date_type":"ESTIMATED","completion_date":"2032-05-14","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}